Clinical trial
Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine…
NCT00460382 · French National Agency for Research on AIDS and Viral Hepatitis, Other · Completed
Key facts
| NCT number | NCT00460382 |
|---|---|
| Title | Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses |
| Official title | Prospective Clinical Trial to Assess Safety and Efficacy of DRV/r(TMC 114/r), ETV(TMC 125) and MK-0518 in Addition to OBT in HIV-1 Infected Patients With Limited to No Treatment Options ANRS 139 TRIO |
| Acronym | ANRS139 TRIO |
| Lead sponsor | French National Agency for Research on AIDS and Viral Hepatitis, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry Janssen-Cilag Tibotec |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | raltegravir potassium, darunavir/ritonavir, etravirine, Optimized background regimen |
| Enrollment | 103 |
| Start date | May 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | Sep 1, 2009 |
| First posted | Apr 13, 2007 |
| Last update posted | Sep 17, 2010 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: